Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment

References

• ZhouSFStructure, function and regulation of P-glycoprotein and its clinical relevance in drug dispositionXenobiotica2008387–880283218668431
   PubMed Web of Science ®Google Scholar
• RaoVVDahlheimerJLBardgettMEChoroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood–cerebrospinal-fluid drug-permeability barrierProc Natl Acad Sci U S A19999673900390510097135
   PubMed Web of Science ®Google Scholar
• TanigawaraYOkamuraNHiraiMTransport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1)J Pharmacol Exp Ther199226328408451359120
   PubMed Web of Science ®Google Scholar
• RosJELibbrechtLGeukenMHigh expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver diseaseJ Pathol2003200555356012898590
   PubMed Web of Science ®Google Scholar
• BlokzijlHVander BorghtSBokLIHDecreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levelsInflamm Bowel Dis200713671072017262809
   PubMed Web of Science ®Google Scholar
• DemeuleMLabelleMRéginaAIsolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoformsBiochem Biophys Res Commun2001281382783411237734
   PubMed Web of Science ®Google Scholar
• NoonanKEBeckCHolzmayerTAQuantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reactionProc Natl Acad Sci U S A19908718716071641976252
   PubMed Web of Science ®Google Scholar
• TrockBJLeonessaFClarkeRMultidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significanceJ Natl Cancer Inst199789139179319214671
   PubMedGoogle Scholar
• Jabr-MilaneLSvan VlerkenLEYadavSMulti-functional nanocarriers to overcome tumor drug resistanceCancer Treat Rev200834759260218538481
   PubMed Web of Science ®Google Scholar
• GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP–dependent transportersNat Rev Cancer200221485811902585
   PubMed Web of Science ®Google Scholar
• YangXSinghAChoyEMDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancerSci Rep20155850925687880
   PubMed Web of Science ®Google Scholar
• DönmezYAkhmetovaLİşeriÖDEffect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cellsCancer Chemother Pharmacol201167482382820563580
   PubMed Web of Science ®Google Scholar
• MengHALiongMXiaTEngineered design of mesoporous silica nanoparticles to deliver DOXorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell lineACS Nano2010484539455020731437
   PubMed Web of Science ®Google Scholar
• ChenAMZhangMWeiDCo-delivery of DOXorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy inmultidrug-resistant cancer cellsSmall20095232673267719780069
   PubMed Web of Science ®Google Scholar
• EmensLAAsquithJMLeathermanJMTimed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor–secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activationJ Clin Oncol200927355911591819805669
   PubMed Web of Science ®Google Scholar
• CaiSThatiSBagbyTRLocalized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancerJ Control Release2010146221221820403395
   PubMed Web of Science ®Google Scholar
• ArouiSBrahimSDe WaardMEfficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231Cancer Lett20092851283819523755
   PubMed Web of Science ®Google Scholar
• DaviesCLLoizidouMCooperAJEffect of γ-linolenic acid on cellular uptake of structurally related anthracyclines in human drug sensitive and multidrug resistant bladder and breast cancer cell linesEur J Cancer199935101534154010673983
   PubMed Web of Science ®Google Scholar
• Ctés-FunesHCoronadoCRole of anthracyclines in the era of targeted therapyCardiovasc Toxicol200772566017652804
   PubMed Web of Science ®Google Scholar
• SimpsonGRRelphKHarringtonKCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesOncolytic Virother20165127579292
   PubMedGoogle Scholar
• ZhengMGongPJiaDPLGA–Lecithin–PEG core-shell nanoparticles for cancer targeted therapyNano Life20122011250002
   Google Scholar
• XiaTKovochichMLiongMPolyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructsACS Nano20093103273328619739605
   PubMed Web of Science ®Google Scholar
• DietrichANeubrandAEffects of particle size and molecular weight of polyethylenimine on properties of nanoparticulate silicon dispersionsJ Am Ceramic Soc2001844806812
   Web of Science ®Google Scholar
• Vallet-RegiMBalasFArcosDMesoporous materials for drug deliveryAngew Chem Int Ed Engl200746407548755817854012
   PubMed Web of Science ®Google Scholar
• SlowingIIVivero-EscotoJLWuCWLinVSMesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriersAdv Drug Deliv Rev200860111278128818514969
   PubMed Web of Science ®Google Scholar
• LeeCHLoLWMouCYSynthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drugAdv Funct Mater2008182032833292
   Web of Science ®Google Scholar
• HuhSWienchJWYooJCOrganic functionalization and morphology control of mesoporous silicas via a co-condensation synthesis methodChem Mater2003152242474256
   Web of Science ®Google Scholar
• YingJYDesign and synthesis of nanostructured catalystsChem Eng Sci200661515401548
   Web of Science ®Google Scholar
• LuJLiongMZinkJIMesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugsSmall2007381341134617566138
   PubMed Web of Science ®Google Scholar
• VigneswaranNWilliamsMDEpidemiologic trends in head and neck cancer and aids in diagnosisOral Maxillofac Surg Clin North Am201426212314124794262
   PubMed Web of Science ®Google Scholar
• ArduinoPGCarrozzoMChiecchioAClinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 casesJ Oral Maxillofac Surg20086681570157918634942
   PubMed Web of Science ®Google Scholar
• de VicenteJCFresnoMFVillalainLVegaJAHernάndez VallejoGExpression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinomaOral Oncol200541328329315743691
   PubMed Web of Science ®Google Scholar
• SchlieveTKolokythasAComplications from surgical treatment of oral cancer In: Radosevich JA, editor Head & Neck Cancer: Current Perspectives, Advances, and ChallengesNew York, NYSpringer2013721749
   Google Scholar
• ChiouSHYuCCHuangCYPositive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinomaClin Cancer Res200814134085409518593985
   PubMed Web of Science ®Google Scholar
• KrishanAFitzCMAndritschIDrug retention, efflux, and resistance in tumor cellsCytometry19972942792859415409
   PubMedGoogle Scholar
• van VeenHWKoningsWNMultidrug transporters from bacteria to man: similarities in structure and functionSemin Cancer Biol1997831831919441947
   PubMed Web of Science ®Google Scholar
• XuDMcCartyDFernandesADelivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vectorMol Ther200511452353015771955
   PubMed Web of Science ®Google Scholar
• ShiZLiangYChenZReversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivoCancer Biol Ther200651394716319528
   PubMed Web of Science ®Google Scholar